SG&A at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s SG&A?
- Medpace Holdings, Inc. (MEDP) reported SG&A of $47.92M in Q1 2026.
- How has Medpace Holdings, Inc.'s SG&A changed year-over-year?
- Medpace Holdings, Inc.'s SG&A decreased by 17.2% year-over-year, from $57.9M to $47.92M.
- What is the long-term trend for Medpace Holdings, Inc.'s SG&A?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s SG&A has grown at a 16.2% compound annual growth rate (CAGR), from $108.42M to $197.56M.
- What does SG&A mean?
- The overhead costs of running the business that are not directly tied to producing services.
- How do you interpret SG&A?
- A decrease relative to revenue indicates operating leverage, whereas a significant increase may suggest aggressive expansion or inefficient administrative scaling.
- How does SG&A compare across companies?
- Standard operating expense category across all public companies.